Filing Details

Accession Number:
0001354488-16-006306
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-19 16:30:24
Reporting Period:
2016-02-02
Filing Date:
2016-02-19
Accepted Time:
2016-02-19 16:30:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
34956 Tenax Therapeutics Inc. TENX Services-Commercial Physical & Biological Research (8731) 262593535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1597439 P. James Mitchum C/O Tenax Therapeutics, Inc.
One Copley Parkway, Suite 490
Morrisville NC 27560
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-02-02 5,100 $2.68 5,100 No 4 P Indirect By James P Mitchum Teresa V Mitchum Revocable Living Trust
Common Stock Acquisiton 2016-02-03 13,900 $2.65 19,000 No 4 P Indirect By James P Mitchum Teresa V Mitchum Revocable Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By James P Mitchum Teresa V Mitchum Revocable Living Trust
No 4 P Indirect By James P Mitchum Teresa V Mitchum Revocable Living Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.66 to $2.69. The reporting person undertakes to provide to Tenax Therapeutics, Inc. (the ?Company?), any security holder of the Company, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.60 to $2.69.